- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06547138
Pilotstudie om effektiviteten og sikkerheten til OPTILENE® SILVER MESH ELASTIC i forebygging av kirurgisk stedsinfeksjon (SSI) og incisional brokk (IH) (SSIHLVER)
Prospektiv beskrivende multisenterpilotstudie om effektiviteten og sikkerheten til Optilene® Silver Mesh Elastic for forebygging av kirurgisk stedsinfeksjon (SSI) og incisional brokk (IH)
The aim of the study is to describe the effectiveness of Optilene® Silver Mesh Elastic on prevention of surgical site infection (SSI) at 6 months follow-up in patients undergoing urgent laparotomy by collecting clinical data on the SSI rates, IH rates and overall clinical performance of Optilene® Silver Mesh Elastic used for the prevention of incisional hernia as prophylactic mesh in patients that require urgent median laparotomy in clinical routine.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Irene Fita Esteban
- Telefonnummer: +34609054401
- E-post: info@bbraun.com
Studer Kontakt Backup
- Navn: José Manuel Molina Villar
- Telefonnummer: +34697502623
- E-post: info@bbraun.com
Studiesteder
-
-
-
Badalona, Spania, 08916
- Hospital Universitari Germans Tries i Pujol
-
Ta kontakt med:
- Joan Francesc Julián, Dr.
-
Hovedetterforsker:
- Joan Francesc Julián, Dr.
-
Badalona, Spania
- Hospital Municipal Badalona
-
Ta kontakt med:
- Jorge Marroquin, Dr.
-
Hovedetterforsker:
- Jorge Marroquin, Dr.
-
Calella, Spania, 08370
- Hospital Comarcal Sant Jaume de Calella
-
Ta kontakt med:
- Paqui Vasco, Dr.
-
Hovedetterforsker:
- Paqui Vasco, Dr.
-
Mataró, Spania, 08304
- Hospital de Mataró
-
Ta kontakt med:
- Berhanu Chimdi, Dr.
-
Hovedetterforsker:
- Berhanu Chimdi, Dr.
-
Santa Coloma de Gramenet, Spania, 08923
- Hospital Fundació Esperit Sant
-
Ta kontakt med:
- Daniel Troyano Escribano, Dr.
-
Hovedetterforsker:
- Daniel Troyano Escribano, Dr.
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
High-risk patients according to the professional criteria (such as but not limited to: age, nutrition, body mass index, comorbidities, etc.) who are undergoing prophylactic mesh implantation to avoid surgical site infection after an emergency or urgent intra-abdominal laparotomy.
Beskrivelse
Inclusion Criteria:
- Adult patients (18 years or older)
- Surgical procedure requiring urgent, primary median laparotomy, which are classified as "Class III/Contaminated" or "Class IV/Dirty-Infected" regarding the CDC classification.
These include but are not limited to:
-
Vascular surgery
-
Colon and rectum
-
Hepatobiliary
-
Gastrointestinal
-
Gynecology
-
Urology
-
Abdominal Aortic Aneurysm (AAA) repair
-
Right hemicolectomy
-
Left hemicolectomy
-
Sigmoidectomy
-
Anterior resection
-
Abdominoperineal amputation
-
Exploratory laparotomy
-
Cholecystectomy
-
Cholecystectomy and choledocotomy
- Written informed consent
Exclusion Criteria:
- Pregnancy
- Breast feeding
- Patients < 18 years old or patients who are still in the growth phase
- Contaminated and infected areas
- Hypersensitivity to silver
- Direct contact with the viscera
- Previous allergic reactions to components of the device
- Patient with previous laparotomy
- Transverse laparotomy
- Patients with previous hernia repair
- Simultaneous participation in another investigational clinical trial (drug or medical studies)
- Patients with active oncologic treatment (chemo and radiotherapy)
- Underlying autoimmune disease
- Recent cardiovascular complication
- Gynecology surgery
- Urology surgery
- Vascular surgery
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Optilene® Silver Mesh Elastic
Prophylactic mesh in high-risk patients |
Prevention of incisional hernia after a prophylactic mesh in high-risk patients |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Surgical Site Infection (SSI) A2/A3 rate
Tidsramme: at 6 months follow-up
|
SSIs remain a significant clinical problem as they are associated with substantial mortality and morbidity and impose severe demands on healthcare resources. Centers for Disease Control and Prevention Surgical Site Infection (SSI) Classification System differentiates Superficial SSI (A1), Deep Incisional SSI (A2) and Infection with involvement of organs/body cavities (A3). Only cases of A2 and A3 are considered for the Primary Outcome and are compared to rates from reference literature |
at 6 months follow-up
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cumulative rate of of postoperative complications during the study period
Tidsramme: at discharge (up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up
|
Numbers of all postoperative complications such as mortality, burst abdomen, bowel obstruction, bulging, necrosis, fistula, wound dehiscence, hematoma, seroma, peritonitis are added to the overall complication rate that is observed over the postoperative course |
at discharge (up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up
|
|
Cumulative Surgical Site Infection (SSI) A2/A3 rate during the study period
Tidsramme: at 1 month, 1 year and 2 year follow-up.
|
Number of the Surgical Site Infection (SSI) (only A2 and A3) rate at every follow-up |
at 1 month, 1 year and 2 year follow-up.
|
|
Incisional hernia (IH) rate during the study period
Tidsramme: repeatedly at 6 months, 1 year and 2 year follow-up.
|
Incisional hernia (IH) is a protrusion of tissue that forms at the site of a healing surgical scar. Incisional hernia refers to abdominal wall hernia at the site of a previous surgical incision. |
repeatedly at 6 months, 1 year and 2 year follow-up.
|
|
Length of hospital stay
Tidsramme: at discharge (approximately up to 10 days after surgery)
|
Number of days the patient has to stay in hospital after the surgery |
at discharge (approximately up to 10 days after surgery)
|
|
Development of Pain: Visual Analogue Scale (VAS)
Tidsramme: at discharge (approximately up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up, using the VAS score
|
This parameter will be noted using the Visual Analogue Scale (VAS) which state "0" at one end representing "no pain" and "100" at the opposite end representing "heavy pain". |
at discharge (approximately up to 10 days after surgery), 1 month, 6 months, 1 year and 2 year follow-up, using the VAS score
|
|
Time to return to work
Tidsramme: at all postoperative examinations with a single value for each individual patient
|
The number of days needed to return to work after the surgery of the individual patient is documented |
at all postoperative examinations with a single value for each individual patient
|
|
Handling of the Optilene® Silver Mesh Elastic
Tidsramme: intraoperatively
|
The handling will be evaluated using a questionnaire (Likert-type scale) with the dimensions Tensile Strength, Absence of memory effect, Elasticity, Stiffness, Surface weight, Thickness, Ease of being fixed with suture, Ease of package extraction as well as an overall opinion in five evaluation levels (excellent=1, very good=2, good=3, satisfied=4, poor=5) |
intraoperatively
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Daniel Troyano Escribano, Dr., Fundació Hospital de l'Esperit Sant
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AAG-G-H-2126
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .